You can get involved in discussing the latest developments in this exciting area about Electric Literature of 5908-62-3, you can also check out more blogs about5908-62-3
Some examples of the diverse research done by chemistry experts include discovery of new medicines and vaccines,Electric Literature of 5908-62-3, improving understanding of environmental issues, and development of new chemical products and materials. In a document type is Patent, and a compound is mentioned, 5908-62-3, 1,1-Dioxo-isothiazolidine, introducing its new discovery.
What is described are BET protein-inhibitory, in particular BRD4-inhibitory 2,3-benzodiazepines of the general formula (I) in which R1a, R1b, R1c, R2, R3, R4, R5, A and X have the meanings given in the description, intermediates for preparing the compounds according to the invention, pharmaceutical compositions comprising the compounds according to the invention and their prophylactic and therapeutic use for hyperproliferative disorders, in particular for tumour disorders. Also described is the use of BET protein inhibitors for benign hyperplasias, atherosclerotic disorders, sepsis, autoimmune disorders, vascular disorders, viral infections, for neurodegenerative disorders, for inflammatory disorders, for atherosclerotic disorders and for the control of male fertility.
You can get involved in discussing the latest developments in this exciting area about Electric Literature of 5908-62-3, you can also check out more blogs about5908-62-3
Reference:
Quinuclidine – Wikipedia,
Quinuclidine | C7H547N | ChemSpider